Anxiety Disorders and Depression Treatment Market Size, Share and Growth Forecast for 2024 - 2031

Anxiety Disorders and Depression Treatment Market by Drug Class (Antidepressants, Anxiolytics, Anticonvulsants, Noradrenergic Agents, Atypical Antipsychotics), Indication (Anxiety, Depression), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region for 2024 to 2031

Industry: Healthcare

Published Date: September-2024

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 182

Report Price

$4900*

Buy Now
Get Customisation

Report ID: PMRREP34763

Table of Content

1. Executive Summary
    1.1. Anxiety Disorders and Depression Treatment Market Snapshot, 2024 and 2031
    1.2. Market Opportunity Assessment, 2023 - 2031, US$ Mn
    1.3. Key Market Trends
    1.4. Future Market Projections
    1.5. Premium Market Insights
    1.6. Industry Developments and Key Market Events
    1.7. PMR Analysis and Recommendations
2. Market Overview
    2.1. Market Scope and Definition
    2.2. Market Dynamics
        2.2.1. Drivers
        2.2.2. Restraints
        2.2.3. Opportunity
        2.2.4. Challenges
        2.2.5. Key Trends
    2.3. Macro-Economic Factors
        2.3.1. Global Sectorial Outlook
        2.3.2. Global GDP Growth Outlook
        2.3.3. Global Healthcare Spending Outlook
    2.4. COVID-19 Impact Analysis
    2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
    3.1. Drug Type Adoption Analysis
    3.2. Regulatory Landscape
    3.3. Value Chain Analysis
        3.3.1. List of Distribution Channel/Marketplaces
            3.3.1.1. Retail
            3.3.1.2. Audiology
            3.3.1.3. E-Commerce
        3.3.2. List of End User (Industry)
    3.4. Key Deals and Mergers
    3.5. PESTLE Analysis
    3.6. Porter’s Five Force Analysis
4. Anxiety Disorders and Depression Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2031)
    4.1. Key Highlights
        4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
        4.1.2. Absolute $ Opportunity
    4.2. Market Size (US$ Mn) Analysis and Forecast
        4.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022
        4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031
    4.3. Anxiety Disorders and Depression Treatment Market Outlook: Drug Class
        4.3.1. Introduction / Key Findings
        4.3.2. Historical Market Size (US$ Mn) Analysis, By Drug Class, 2018-2022
        4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023-2031
            4.3.3.1. Antidepressants
            4.3.3.2. Anxiolytics
            4.3.3.3. Anticonvulsants
            4.3.3.4. Noradrenergic Agents
            4.3.3.5. Atypical Antipsychotics
    4.4. Market Attractiveness Analysis: Drug Class
    4.5. Anxiety Disorders and Depression Treatment Market Outlook: Indication
        4.5.1. Introduction / Key Findings
        4.5.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2018-2022
        4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023-2031
            4.5.3.1. Anxiety
            4.5.3.2. Depression
    4.6. Market Attractiveness Analysis: Indication
    4.7. Anxiety Disorders and Depression Treatment Market Outlook: Distribution Channel
        4.7.1. Introduction / Key Findings
        4.7.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2018-2022
        4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023-2031
            4.7.3.1. Hospital Pharmacy
            4.7.3.2. Retail Pharmacy
            4.7.3.3. Online Pharmacy
    4.8. Market Attractiveness Analysis: Distribution Channel
5. Anxiety Disorders and Depression Treatment Market Outlook: Region
    5.1. Key Highlights
    5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018-2022
    5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023-2031
        5.3.1. North America
        5.3.2. Europe
        5.3.3. East Asia
        5.3.4. South Asia and Oceania
        5.3.5. Latin America
        5.3.6. Middle East & Africa
    5.4. Market Attractiveness Analysis: Region
6. North America Anxiety Disorders and Depression Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2031)
    6.1. Key Highlights
    6.2. Pricing Analysis
    6.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018-2022
        6.3.1. By Country
        6.3.2. By Drug Class
        6.3.3. By Indication
        6.3.4. By Distribution Channel
    6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023-2031
        6.4.1. U.S.
        6.4.2. Canada
    6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023-2031
        6.5.1. Antidepressants
        6.5.2. Anxiolytics
        6.5.3. Anticonvulsants
        6.5.4. Noradrenergic Agents
        6.5.5. Atypical Antipsychotics
    6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023-2031
        6.6.1. Anxiety
        6.6.2. Depression
    6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023-2031
        6.7.1. Hospital Pharmacy
        6.7.2. Retail Pharmacy
        6.7.3. Online Pharmacy
    6.8. Market Attractiveness Analysis
7. Europe Anxiety Disorders and Depression Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2031)
    7.1. Key Highlights
    7.2. Pricing Analysis
    7.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018-2022
        7.3.1. By Country
        7.3.2. By Drug Class
        7.3.3. By Indication
        7.3.4. By Distribution Channel
    7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023-2031
        7.4.1. Germany
        7.4.2. France
        7.4.3. U.K.
        7.4.4. Italy
        7.4.5. Spain
        7.4.6. Russia
        7.4.7. Türkiye
        7.4.8. Rest of Europe
    7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023-2031
        7.5.1. Antidepressants
        7.5.2. Anxiolytics
        7.5.3. Anticonvulsants
        7.5.4. Noradrenergic Agents
        7.5.5. Atypical Antipsychotics
    7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023-2031
        7.6.1. Anxiety
        7.6.2. Depression
    7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023-2031
        7.7.1. Hospital Pharmacy
        7.7.2. Retail Pharmacy
        7.7.3. Online Pharmacy
    7.8. Market Attractiveness Analysis
8. East Asia Anxiety Disorders and Depression Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2031)
    8.1. Key Highlights
    8.2. Pricing Analysis
    8.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018-2022
        8.3.1. By Country
        8.3.2. By Drug Class
        8.3.3. By Indication
        8.3.4. By Distribution Channel
    8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023-2031
        8.4.1. China
        8.4.2. Japan
        8.4.3. South Korea
    8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023-2031
        8.5.1. Antidepressants
        8.5.2. Anxiolytics
        8.5.3. Anticonvulsants
        8.5.4. Noradrenergic Agents
        8.5.5. Atypical Antipsychotics
    8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023-2031
        8.6.1. Anxiety
        8.6.2. Depression
    8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023-2031
        8.7.1. Hospital Pharmacy
        8.7.2. Retail Pharmacy
        8.7.3. Online Pharmacy
    8.8. Market Attractiveness Analysis
9. South Asia & Oceania Anxiety Disorders and Depression Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2031)
    9.1. Key Highlights
    9.2. Pricing Analysis
    9.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018-2022
        9.3.1. By Country
        9.3.2. By Drug Class
        9.3.3. By Indication
        9.3.4. By Distribution Channel
    9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023-2031
        9.4.1. India
        9.4.2. Southeast Asia
        9.4.3. ANZ
        9.4.4. Rest of South Asia & Oceania
    9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023-2031
        9.5.1. Antidepressants
        9.5.2. Anxiolytics
        9.5.3. Anticonvulsants
        9.5.4. Noradrenergic Agents
        9.5.5. Atypical Antipsychotics
    9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023-2031
        9.6.1. Anxiety
        9.6.2. Depression
    9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023-2031
        9.7.1. Hospital Pharmacy
        9.7.2. Retail Pharmacy
        9.7.3. Online Pharmacy
    9.8. Market Attractiveness Analysis
10. Latin America Anxiety Disorders and Depression Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2031)
    10.1. Key Highlights
    10.2. Pricing Analysis
    10.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018-2022
        10.3.1. By Country
        10.3.2. By Drug Class
        10.3.3. By Indication
        10.3.4. By Distribution Channel
    10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023-2031
        10.4.1. Brazil
        10.4.2. Mexico
        10.4.3. Rest of Latin America
    10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023-2031
        10.5.1. Antidepressants
        10.5.2. Anxiolytics
        10.5.3. Anticonvulsants
        10.5.4. Noradrenergic Agents
        10.5.5. Atypical Antipsychotics
    10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023-2031
        10.6.1. Anxiety
        10.6.2. Depression
    10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023-2031
        10.7.1. Hospital Pharmacy
        10.7.2. Retail Pharmacy
        10.7.3. Online Pharmacy
    10.8. Market Attractiveness Analysis
11. Middle East & Africa Anxiety Disorders and Depression Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2031)
    11.1. Key Highlights
    11.2. Pricing Analysis
    11.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018-2022
        11.3.1. By Country
        11.3.2. By Drug Class
        11.3.3. By Indication
        11.3.4. By Distribution Channel
    11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023-2031
        11.4.1. GCC Countries
        11.4.2. Egypt
        11.4.3. South Africa
        11.4.4. Northern Africa
        11.4.5. Rest of Middle East & Africa
    11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023-2031
        11.5.1. Antidepressants
        11.5.2. Anxiolytics
        11.5.3. Anticonvulsants
        11.5.4. Noradrenergic Agents
        11.5.5. Atypical Antipsychotics
    11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023-2031
        11.6.1. Anxiety
        11.6.2. Depression
    11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023-2031
        11.7.1. Hospital Pharmacy
        11.7.2. Retail Pharmacy
        11.7.3. Online Pharmacy
    11.8. Market Attractiveness Analysis
12. Competition Landscape
    12.1. Market Share Analysis, 2023
    12.2. Market Structure
        12.2.1. Competition Intensity Mapping By Market
        12.2.2. Competition Dashboard
    12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
        12.3.1. Pfizer Inc
            12.3.1.1. Overview
            12.3.1.2. Segments and Drug Class
            12.3.1.3. Key Financials
            12.3.1.4. Market Developments
            12.3.1.5. Market Strategy
        12.3.2. H. Lundbeck A/S
        12.3.3. Glaxo SmithKline Pharmaceuticals Ltd.
        12.3.4. Merck & Co., Inc.
        12.3.5. Eli Lilly & Company
        12.3.6. AstraZeneca
        12.3.7. Bristol-Myers Squibb
        12.3.8. Johnson & Johnson
        12.3.9. AbbVie Inc.
        12.3.10. Sanofi
13. Appendix
    13.1. Research Methodology
    13.2. Research Assumptions
    13.3. Acronyms and Abbreviations

Sample Report

Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

List Of Table

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate